Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
Authors Ksenia Cassidy, CJ Healy, Eva Henje and Wendy D’Andrea Published March 20, 2024 Abstract Challenging experiences in ayahuasca...
top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Eleanor Taylor
Mar 187 min read
Psilocybin shows promise in supporting symptoms of Premenstrual Dysphoric Disorder
Pioneering research highlights the potential for treating the symptoms of Premenstrual Dysphoric Disorder (PMDD). Written by Eleanor...
Sean Matthew Viña
Jan 91 min read
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Minorities’ diminished psychedelic returns: Cardio-metabolic health. Race differences remain a critically understudied gap in psychedelic li
Drug Science
Dec 11, 20232 min read
Patients with a terminal diagnosis want to access psilocybin in the UK
Terminal patients are calling for compassionate access to be granted for psilocybin — the psychedelic substance found in fungi known as ‘mag
James Bunn
Dec 11, 20235 min read
Psilocybin for Existential Distress
Read our latest report on why patients experiencing 'Existential Distress'
ought to be permitted access to psilocybin-assisted psychotherap
Octavian Dixon Ritchie, Cameron Donley and more
Sep 6, 20231 min read
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
On February 3, 2023, the Therapeutic Goods Administration (TGA), Australian Government Department of Health and Aged Care, announced that on
Anoek Van Vugt, Josjan Zijlmans and more
Sep 1, 20231 min read
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
PTSD in adolescence causes much suffering and has substantial health-care costs. The purpose of this study is to investigate the perspective
James Bunn
Jun 28, 20235 min read
Psilocybin for Existential Distress - the UK needs to show some compassion
Psilocybin has shown promise as a treatment for existential distress, a condition marked by feelings of hopelessness, despair, and a lack of
Sean Viña and Amanda Stephens
Jun 23, 20231 min read
Minorities’ diminished psychedelic returns
Although there is a growing support for the use of psychedelics to improve the health of marginalized groups, there are some critical gaps.
Sally Turner
Jun 12, 20237 min read
Drugs: What are they good for? - 5-MeO-DMT
5-methoxy-N,N-dimethyltryptamine, or ‘toad venom’ as it’s better known, is a tryptamine psychedelic that occurs naturally in multiple specie
Rayyan Zafar, Maxim Siegel and more
Jun 12, 20231 min read
Psychedelic therapy in the treatment of addiction: the past, present and future
Psychedelic therapy has witnessed a resurgence in interest in the last decade from the scientific and medical communities with evidence now
Adriana D’Arienzo and Giorgio Samorini
Jun 6, 20231 min read
Italian psychedelic therapies of the past century: An historical overview
In recent years, the historical record of psychedelic therapy in Europe and the Americas has undergone considerable revision.
Paul McCrone, Henry Fisher and more
Jun 2, 20232 min read
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model
There is growing evidence to support the use of the psychedelic drug psilocybin for difficult-to-treat depression. This paper compares the c
Meg Spriggs, Ashleigh Murphy-Beiner and more
May 11, 20232 min read
ARC: a framework for access, reciprocity and conduct in psychedelic therapies
The field of psychedelic assisted therapy (PAT) is growing at an unprecedented pace. The immense pressures this places on those working in t
Jaden Brandt
Apr 26, 20231 min read
A roadmap for psychedelic pharmacy in Canada
The unprecedented progress in the science and clinical investigation of psychedelic medicine will require those in healthcare leadership and
Cyrus Rohani-Shukla
Apr 14, 20235 min read
Psychedelics and Philosophy
The primary intention behind most psychedelic research is to try to understand whether psychedelics can provide safe and effective therapeut
Kellen Russoniello, Sheila Vakharia and more
Apr 11, 20231 min read
Decriminalisation of drug possession in Oregon: Analysis and early lessons
In November 2020, Oregon voters approved Measure 110, a ballot initiative that decriminalized possession of small quantities of all drugs an
Drug Science
Feb 2, 20234 min read
Psychedelics for managing pain
Dr. Joanna Kempner Dr. Joanna Kempner is a professor of sociology at Rutgers University, where she studies the overlap of science,...
Tiago Vasconcelos
Jan 5, 20238 min read
Neuroplasticity in Mental Health Recovery: Prompting the Brain to Cure Itself
Written by Tiago Vasconcelos Psychiatric disorders can be considered to disturb the brain’s equilibria, emerging when different factors...
Drug Science
Dec 28, 20224 min read
Busting the Myths Surrounding Psychedelics
Prof. Jo Neill The generalised public perception of psychedelic drugs is rooted in their legal categorisation as a Class A, Schedule 1...
Professor David Nutt
Dec 8, 20225 min read
Three weeks down under: My Mind Medicine Australia Psychedelic Lecture Tour
Written by Professor David Nutt I have just come back from a 3-week lecture tour of South-Eastern Australia supporting the cause of the...
bottom of page